A study on profile of patients with parotid swellings attending infectious disease hospital, Hyderabad, Telangana


  • Phani Bhushan Ivaturi Department of Otorhinolaryngology, Gandhi Medical College, Hyderabad, Telangana, India
  • Asma . Department of Community Medicine, Gandhi Medical College, Hyderabad, Telangana, India




Mumps, Parotid swelling, MMR vaccine, Subclinical cases


Background: Mumps is an acute infectious disease caused by RNA virus. Clinically, the disease is presented as non suppurative enlargement and tenderness of one or both the parotid glands. The annual incidence of mumps in the absence of immunization is in the range of 100-1000 cases/100000 population. Mumps mostly occurs in children in age group of 5-9 years. The objectives of the study were to describe the epidemiological factors of cases admitted with parotid swelling; to describe the clinical features of patients admitted with parotid swelling; to assess the demographic factors in relation to complications.

Methods: A cross sectional record based retrospective study was carried out at Sir Ronald Ross Institute of Tropical and Communicable Diseases, Hyderabad. All the cases admitted in year 2016 with unilateral or bilateral parotid swellings were included in the study. The study was carried out for 2 months.  

Results: The mean age of study population in present study was found to be 11.23 years. Around 35.9% of cases were found in the age group of 6-10 years. Males constituted 53.9% of study population and females were 46.1%. The mean duration between the onset of symptoms and admission in hospital was found to be 3.5 days. The most common clinical presentation was fever, parotid swelling and earache.

Conclusions: Control of Mumps is difficult as the disease is highly infectious. Long and variable incubation period along with subclinical cases makes the control difficult. However, routine MMR vaccination as part of national immunization schedule can help in be preventing the epidemics.



Park K. Park’s textbook of Preventive and Social Medicine. 24th edition. Jabalpur: Banarsi Das Bhanot; 2017: 162-163.

WHO (2007), Weekly Epidemiological Record, 16th Feb, No 7, 2007.

World Health Organization (WHO) - Vaccines and diseases. Mumps. Available at: http://www.who.int/ immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/mumps/en/. Accessed on 23 February 2018.

World Health Organization (WHO) – Immunization, Vaccines and Biologicals. Mumps. Available at: http://www.who.int/immunization/diseases/mumps/en/. Accessed on 23 February 2018.

Vuori M, Lahikainen EA, Peltonen T. Perceptive deafness in connection with mumps. A study of 298 servicemen suffering from mumps. Acta Otolaryngol. 1962;55:231–6.

Integrated Disease Surveillance Program (IDSP) National Centre for Disease Control (NCDC), Directorate General of Health Services, Ministry of Health and Family welfare, Government of India. Available at: http://idsp.nic.in/idsp/IDSP/ rcntobrk.pdf. Accessed on February 23, 2018.

National Health Portal India. Mumps. Published on Mar 22nd 2017. Available at https://www.nhp.gov. in/disease/communicable-disease/mumps. Accessed on 23 February 2018.

Indranil S, Dibakar H, Bobby P, Shrivastava P, Dilip DK, Mousumi P, et al. An epidemiological investigation of Mumps outbreak in a slum of Kolkata. J Commun Dis. 2012;44(1):29-36.

Geeta MG, Kumar PK. Mumps-need for urgent action. Indian Pediatr. 2004;41:1181-2.

Ghatage ST, Kakade GM. An outbreak of mumps meningoencephalitis in Sangli district. Indian Pediatr. 2007;44:235.

Raut CG, Sinha DP, Jay aprakash H, Hanumiah H, Manjunatha MJ. Mumps disease outbreak in Davangere district of Karnataka, India. Indian J Med Microbiol. 2015;33:378-82.

Li R, Cheng S, Luo C, Rutherford S, Cao J, Xu Q, et al. Epidemiological Characteristics and Spatial-Temporal Clusters of Mumps Disease in Shandong Province, China, 2005–2014. Sci Rep. 2017;7:46328.

Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Human Vaccines & Immunotherapeutics. 2015;11(6):1413-7.

Martina H, Radomira L, Smiskova D, Kristyna H, Jirincova H, Nováková L, et al. Mumps in the Czech Republic 2013: Clinical Characteristics, Mumps virus Genotyping, and epidemiological links. Cent Eur J Public Health. 2016;24(1):22-8.

Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011;17(4):661-7.






Original Research Articles